The Department of Health and Human Services (HHS) has issued a new notice of funding opportunity for Title X, the federal program providing reproductive health services to approximately 2.8 million low and no-cost birth control and other sexual and reproductive health services every year. The updated guidelines shift the program’s focus toward fertility and pregnancy support, drawing criticism from reproductive health advocates who argue the move undermines the program’s long-standing mandate to provide comprehensive contraceptive care.
Shift in Title X Funding Priorities
Title X has historically functioned as a primary source for subsidized birth control, STI testing, and reproductive health counseling. According to the Office of Population Affairs (OPA), the newly released funding notice emphasizes "body literacy," addressing infertility, and managing reproductive conditions like endometriosis.
The document references "overmedicalization" in relation to contraception, noting that reports indicate a decrease in females’ current use of any contraception. While the program continues to include fertility services, advocates at the Guttmacher Institute argue the new criteria prioritize pregnancy-related outcomes over the bodily autonomy and contraceptive access that previously defined the program’s statutory purpose.
Legal Challenges and Administrative Oversight
The National Family Planning and Reproductive Health Association (NFPRHA) filed a lawsuit in June challenging the administration’s changes to the funding notice. The plaintiffs contend that the administration is attempting to rewrite the scope of the program via grant requirements that conflict with the original legislative intent.
Clare Coleman, president of the NFPRHA, stated that the administration’s approach represents an attempt to "hijack" the program. Concerns have also been raised regarding the leadership of the Office of Population Affairs under Assistant Secretary for Health Brian Christine. Critics point to Christine’s history of supporting crisis pregnancy centers—facilities that often do not provide the full spectrum of medical contraceptive services—as evidence of a broader shift in how Title X funds may be distributed.
Pronatalism and Federal Policy
The changes to Title X align with a broader, administration-wide focus on increasing U.S. birth rates. This "pronatalist" approach has been reflected in several recent federal actions:
- Embryo Adoption Awareness: In June, HHS released a funding notice for the Embryo Adoption Awareness and Services program, which classifies embryos as "children already in existence," a move critics argue advances fetal personhood legal theories.
- Economic Incentives: The administration recently launched "Trump Accounts," which provide $1,000 to children born between January 2025 and December 2028.
- Programmatic Reorientation: HHS officials have expressed concerns regarding declining birth rates and have sought to integrate fertility-focused services into existing public health frameworks.
Comparison of Program Guidance
The current funding notice differs significantly from the 2024 OPA handbook, which explicitly categorized contraceptive products and natural family planning as core services. While the 2024 handbook framed fertility services as one component of a broader reproductive health strategy, the new guidance centers pregnancy and fertility support as primary objectives.
Advocates argue that this transition effectively marginalizes the contraceptive services that Congress intended the program to provide. As the legal battle proceeds, the future of Title X remains in flux, with providers caught between the administration’s new policy directives and the program’s historical mandate to ensure equitable access to sexual and reproductive health care.
Keep reading